A Next Generation Theranostic PSMA Ligand for 64Cu and 67Cu-Based Prostate Cancer Imaging and Therapy

被引：0
|
作者：
Ponnala, Shashikanth [7 ]
Amor-Coarasa, Alejandro [4 ]
Kelly, James [6 ]
Zia, Nicholas [1 ,2 ]
Clarence, Williams [7 ]
Nikolopoulou, Anastasia [7 ]
Donnelly, Paul [3 ]
Babich, John [5 ]
机构：
[1] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia
[2] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Weill Cornell Med Coll, Bronx, NY USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Weill Cornell Med, New York, NY USA
[7] Weill Cornell Med, Radiol, New York, NY USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1005
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Theranostic 64Cu-DOTHA2-PSMA for metastatic prostate cancer treatment, a preclinical study
    Milot, M. C.
    Benesty, O. Belissant
    Dumulon-Perreault, V.
    Ait-Mohand, S.
    Rousseau, E.
    Richard, P.
    Guerin, B.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S24 - S24
  • [22] Cyclotron based production of 64Cu/67Cu diagnostic and theragnostic pair
    Lee, J.
    Park, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S9 - S9
  • [23] Theranostic 64Cu-DOTHA2-PSMA allows low toxicity radioligand therapy in mice prostate cancer model
    Milot, Marie-Christine
    Belissant-Benesty, Ophelie
    Dumulon-Perreault, Veronique
    Ait-Mohand, Samia
    Geha, Sameh
    Richard, Patrick O. O.
    Rousseau, Etienne
    Guerin, Brigitte
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Single-Center Comparison of [64Cu]-DOTAGA-PSMA and [18F]-PSMA PET-CT for Imaging Prostate Cancer
    Mirzaei, Siroos
    Lipp, Rainer
    Zandieh, Shahin
    Leisser, Asha
    CURRENT ONCOLOGY, 2021, 28 (05) : 4167 - 4173
  • [25] Development of an automated production process of [64Cu][Cu (ATSM)] for positron emission tomography imaging and theranostic applications
    Liu, Tengzhi
    Redalen, Kathrine Roe
    Karlsen, Morten
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2022, 65 (07): : 191 - 202
  • [26] [64Cu(SarAr)]2+ for tumor imaging and therapy
    Martini, D.
    Panichelli, P.
    Valentini, G.
    Paparelli, M.
    Malizia, C.
    Polanzan, L.
    Colonna, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S330 - S330
  • [27] In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy
    Lewis, MR
    Wang, M
    Axworthy, DB
    Theodore, LJ
    Mallet, RW
    Fritzberg, AR
    Welch, MJ
    Anderson, CJ
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (08) : 1284 - 1292
  • [28] Radiological properties of Next Generation Theranostics (Cu-64/Cu-67)
    Biggin, Colin
    Harris, Matt
    Hedt, Amos
    Jeffery, Charmaine
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [29] [64Cu] Cu-NOTA-and [64Cu]Cu-NODAGA-6Ahx-RM2 GRPR-peptide antagonists for the targeting of prostate cancer
    Makris, Georgios
    Shegani, Antonio
    Kuchuk, Marina
    Bandari, Rajendra
    Smith, Charles
    Hennkens, Heather
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S422 - S423
  • [30] Preclinical and clinical evaluation of [64Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [18F]FDG imaging
    Fei Chen
    Hao Zhang
    Yousheng Zhan
    Xiaohong Huang
    Zongxi He
    Daiyuan Ma
    Tielong Tang
    Suping Li
    Scientific Reports, 15 (1)
12345